Journal of Neuroscience, Vol 15, 7282-7292, Copyright © 1995 by Society for Neuroscience
Age-associated impairments in a test of attention: evidence for involvement of cholinergic systems
DN Jones, JC Barnes, DL Kirkby and GA Higgins
Glaxo Unit for Behavioral Psychopharmacology, Division of Biosciences, University of Hertfordshire, Hatfield, Herts, United Kingdom.
We trained three groups of rats, young (Y; 3 months at the start of study),
middle aged (MA; 15 months), and aged (AG; 22 months), in the serial
five-choice serial reaction time task, a test of attention. There were
clear age-related differences in task acquisition: Y acquired the task
quicker than MA rats, which learned faster than AG rats. A subgroup of AG
rats [AG(I)] could not reach criterion (> 80% correct, < 20%
omissions under standard conditions of 0.5 sec stimulus duration, 5 sec
limited hold). Accordingly, they were tested under conditions of 1 sec
stimulus duration. Having acquired the task, under standard conditions both
MA and AG groups were slower to make a correct response but not to collect
the food reward. Furthermore, parameter changes, particularly reductions in
stimulus duration and intensity, revealed further age-related changes in
accuracy. Following completion of these studies, animals were trained in a
simpler one-choice task. Importantly, reducing stimulus duration/intensity
in this task revealed no differences between Y and MA/AG groups, although
AG(I) rats were impaired. This dissociation between MA/AG impairments in
the one- and five-choice task suggests that these animals may show
attentional deficits compared with Y rats, which are independent of changes
in sensory (visual), motor function, or motivation. Finally, the MA deficit
in attention was partially reversed by tacrine pretreatment (3 mg/kg). Also
scopolamine (0.01-0.075 mg/kg) and mecamylamine (0.3-5 mg/kg) pretreatment
impaired choice accuracy of MA but not Y rats. Taken together, the drug
studies imply that the attentional deficits may at least be partially due
to changes in cholinergic function.